Perham v. GlaxoSmithKline, LLC
| Docket Number | 21-1517 |
| Decision Date | 09 January 2023 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
2 cases
-
DiCroce v. McNeil Nutritionals, LLC
... ... Inc., Mktg., Sales Pracs. &Prods. Liab. Litig., 54 ... F.4th 28, 35 (1st ... consumers from "harmful products." In re Zofran ... (Ondansetron) Prods. Liab. Litig., 57 ... ...
-
Ferrari v. Vitamin Shoppe Indus. LLC
... ... Perham v. GlaxoSmithKline LLC ( In re Zofran tron) Prods. Liab. Litig. ), 57 F.4th 327, 330 (1st Cir ... ...
3 firm's commentaries
-
What A Difference A Decade+ Makes
...data precluded an assessment of teratogenic risk. See Perham v. GlaxoSmithKline LLC (In re Zofran Ondansetron Prods. Liab. Litig.), 57 F.4th 327 (1st Cir. 2023). In Zofran, the passage of time helped crystalize the FDA’s regulatory stance about the proposed birth defect warning. Events that......
-
Product Liability Update - April 2023
...Similar Labeling With Awareness Of The Cited Studies In Perham v. GlaxoSmithKline LLC (In re Zofran Ondansetron Prods. Liab. Litig.), 57 F.4th 327 (1st Cir. 2023), plaintiffs brought failure-to-warn claims against a pharmaceutical manufacturer in a multi-district litigation centralized in t......
-
The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023
...here they are, our 2023 top ten prescription medical product liability decisions In re Zofran (Ondansetron) Products Liability Litigation, 57 F.4th 327 (1st Cir. 2023). Zofran demonstrated, yet again, that where applicable, preemption is the strongest defense our clients have. Dismissal of ......